Characteristics and outcomes of children with acute myeloid leukemia and Down syndrome who are ineligible for clinical trials due to severe comorbidities-Reference-Cited by-同舟云学术

Characteristics and outcomes of children with acute myeloid leukemia and Down syndrome who are ineligible for clinical trials due to severe comorbidities

Published:2019-08-18 Issue:11 Volume:66 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Nakashima Kentaro¹²^ORCID,Hasegawa Daisuke²³,Tomizawa Daisuke²⁴^ORCID,Miyamura Takako²⁵,Hama Asahito²⁶,Iwamoto Shotaro²⁷,Terui Kiminori²⁸^ORCID,Adachi Souichi²⁹,Taga Takashi²¹⁰^ORCID

Affiliation:

1. Department of PediatricsGraduate School of Medical SciencesKyushu University Fukuoka Japan

2. AML CommitteeJapan Children's Cancer Group Nagoya Japan

3. Department of PediatricsSt. Luke's International Hospital Tokyo Japan

4. Division of Leukemia and LymphomaChildren's Cancer CenterNational Center for Child Health and Development Tokyo Japan

5. Department of PediatricsOsaka University School of Medicine Osaka Japan

6. Department of Hematology and OncologyChildren's Medical CenterJapanese Red Cross Nagoya First Hospital Nagoya Japan

7. Department of PediatricsMie University School of Medicine Mie Japan

8. Department of PediatricsHirosaki University Graduate School of Medicine Hirosaki Japan

9. Department of Human Health SciencesKyoto University Kyoto Japan

10. Department of PediatricsShiga University of Medical Science Otsu Japan

Funder